This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Dr. Stricker replies to Methodological Concerns Regarding the Relation Between Mefloquine and Serious Psychiatric Events in Females

Bruno H. Ch. Stricker, MB, PhD

Published: January 16, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: My colleagues and I highly appreciate the interest in our article1 by Dr. Tepper and Ms. Strauss. My response will follow the sequence of their 5 points.

First, the questionnaire response rate in our study was 67%, 63% for cases and 67% for matched controls (intended case: control ratio = 1:6). This difference in response rate was not statistically significant.’ ‹’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 67

Quick Links: Psychiatry

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...